Qualitative to assessment of barriers and facilitators to HIV treatment.
Qualitative to assessment of barriers and facilitators to HIV treatment.
复制标题
DOI:
10.1016/j.jana.2010.11.001
复制
发表时间:
2011-07
影响因子:
2
通讯作者:
Konkle-Parker, Deborah
中科院分区:
文献类型:
--
作者:
Williams, Bryman;Amico, K. Rivet;Konkle-Parker, Deborah
The advent of effective treatments for HIV has offered millions of people living with HIV (PLWH) the opportunity to improve their longevity and quality of life (Jelsma, MacLean, Hughes, Tinise, & Darder, 2005). A necessary prerequisite for accessing these treatments is enrolling and subsequently remaining in clinical care. Levels of engagement in HIV care can be seen on a continuum:‘‘a spectrum of patient care, ranging from initial diagnosis to full engagement in care’’(Cheever, 2007, p. 117). For reasons that remain underexplored and poorly understood, a sizable portion of PLWH in the United States do not fully engage in HIV care, which is defined here as enrolling in care in a timely manner and subsequently attending care at the recommended intervals for monitoring and follow-up. Across all points on the continuum of care, there are considerable proportions of PLWH in the United States who are not engaged in care. A reported 20% to 40% of PLWH in the United States are presently unaware of their HIV infection, 20% to 40% of PLWH who are aware of their HIV infection do not enter care in a timely manner, and approximately 33% of those who enter care do not use it at the recommended intervals (Mugavero et al., 2009). Clearly, efforts are needed to better understand barriers and facilitators to engaging in HIV care so as to develop and implement effective interventions that will promote higher rates of utilization over the care continuum.Presently, considerable efforts through national initiatives to promote routine rapid HIV testing in adult health care settings target reducing the number of individuals who remain unaware of their HIV status (Centers for Disease Control and Prevention [CDC], 2007). Arguably, however, knowledge of HIV infection is a necessary but insufficient condition for better control of HIV at a personal, community, or epidemiological level. Effective medical treatment and persistence in HIV care are needed to achieve and sustain viral suppression, which could further reduce transmission risk and would offer a host of benefits to the health and longevity of the individual. Presently, however, barriers and facilitators to staying in HIV care once initiated are underexplored in the literature, limiting the empirical guidance needed to develop and implement effective retention-in-care interventions.
登录
查看更多内容
影响因子:
4.9
作者:
Tobias, Carol R.;Cunningham, William;Drainoni, Mari-Lynn
通讯作者:
Drainoni, Mari-Lynn
DOI:
10.1080/09540120412331336652
发表时间:
2005-08-01
影响因子:
1.7
作者:
Giordano, TP;Visnegarwala, F;Grimes, RM
通讯作者:
Grimes, RM
DOI:
10.1080/09540120412331299780
发表时间:
2005-04-01
影响因子:
1.7
作者:
Stewart, KE;Cianfrini, LR;Walker, JF
通讯作者:
Walker, JF
DOI:
10.1086/595705
发表时间:
2009-01-15
期刊:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
影响因子:
--
作者:
Mugavero MJ;Lin HY;Willig JH;Westfall AO;Ulett KB;Routman JS;Abroms S;Raper JL;Saag MS;Allison JJ
通讯作者:
Allison JJ
DOI:
10.1016/j.jana.2010.06.002
发表时间:
2011-03
影响因子:
2
作者:
Konkle-Parker, Deborah J.;Amico, K. Rivet;Henderson, Harold M.
通讯作者:
Henderson, Harold M.